Skip to main content
. Author manuscript; available in PMC: 2023 Dec 13.
Published in final edited form as: Circulation. 2022 Nov 2;146(24):e334–e482. doi: 10.1161/CIR.0000000000001106

Recommendation for Antiplatelet Therapy in TAA

COR LOE Recommendation
2a C-EO 1. In patients with atherosclerotic TAA and concomitant aortic atheroma or PAU, the use of low-dose aspirin is reasonable, unless contraindicated.1,2